Qimin Zhan has received Changjiang Scholarship of Ministry of Education. He is also a winner of the National Science Foundation for Distinguished Young Scholars and the national candidate of New Century Talent Project. He’s a chief expert of Innovation Group of the National Natural Science Foundation of China, and a Chief scientist of the National Program on Key Basic Research Project of China (973 Program). He has been awarded Honorary Professorship at Kings College and University of Manchester, Visiting Professorship at Juntendo University and Keio University.

 

He currently serves as Chairman of Chinese Society of Microcirculation, Vice President of Chinese Medical Doctor Association, Vice President of China International Exchange and Promotive Association for Medical and Health Care, and Chairman of the Overseas Physicians division of the Western Returned Scholars Association.

 

He has been engaged in the research of molecular oncology and translational medicine for a long time. He made outstanding achievements in the field of molecular oncology, including the first demonstrations in tumor suppressor p53-regulated signaling pathways in the cell cycle checkpoints and genomic stability following genotoxic stress. He also made the first demonstration of genomic alterations in human esophageal squamous cell carcinoma (ESCC), defining significant mutated genes, copy number variations and structure veriations during the ESCC development. He has published more than 300 peer-reviewed papers and 13 books in international journals of medical biology. He has been invited as keynote speakers of national and international conferences for over 120 times and served as co-chairman of 15 international academic conferences.